Palatin Technologies, Inc. Share Price Nyse
Equities
PTN
US6960773041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 41.27L 34Cr | Sales 2025 * | 52.5L 44Cr | Capitalization | 3.29Cr 273.99Cr |
---|---|---|---|---|---|
Net income 2024 * | -3.4Cr -282.99Cr | Net income 2025 * | -3Cr -249.7Cr | EV / Sales 2024 * | 7.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.27 x |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-1.73
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on Palatin Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Carl Spana
FOU | Founder | 61 | 21/86/21 |
Stephen Wills
DFI | Director of Finance/CFO | 67 | 01/97/01 |
John Dodd
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Prendergast
FOU | Founder | 70 | 21/86/21 |
Carl Spana
FOU | Founder | 61 | 21/86/21 |
Robert deVeer
BRD | Director/Board Member | 78 | 01/98/01 |
1st Jan change | Capi. | |
---|---|---|
+8.36% | 12TCr | |
+13.01% | 11TCr | |
-13.59% | 2.23TCr | |
-3.99% | 2.16TCr | |
-5.62% | 1.82TCr | |
-39.93% | 1.76TCr | |
+7.67% | 1.43TCr | |
+33.33% | 1.24TCr | |
-28.05% | 828.11Cr |
- Stock Market
- Equities
- PTN Stock
- PTN Stock